A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The race to ...
LOS ANGELES/LONDON (Reuters) - AstraZeneca Plc has won U.S. approval to market its cholesterol-lowering drug Crestor to treat the clogging of arteries, which may boost sales of the blockbuster drug in ...
AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes for a potential blockbuster that could be part of a powerful combination ...
Tens of millions of Americans have high cholesterol, which increases the risk of heart disease. Here & Now ‘s Peter O’Dowd ...
LONDON (CBS.MW) -- AstraZeneca on Monday said a study presented at the European Association for the Study of Diabetes shows that its Crestor statin is more effective at reducing bad cholesterol and ...
LONDON, Jan 21 (Reuters) - The patent expires later this year on the world's biggest selling drug, Lipitor, and it is causing a headache not just for maker Pfizer but also for arch-rival AstraZeneca .
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback